226 related articles for article (PubMed ID: 25395432)
1. Contrasting Cholesterol Management Guidelines for Adults with CKD.
Colantonio LD; Baber U; Banach M; Tanner RM; Warnock DG; Gutiérrez OM; Safford MM; Wanner C; Howard G; Muntner P
J Am Soc Nephrol; 2015 May; 26(5):1173-80. PubMed ID: 25395432
[TBL] [Abstract][Full Text] [Related]
2. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
3. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations.
Muntner P; Colantonio LD; Cushman M; Goff DC; Howard G; Howard VJ; Kissela B; Levitan EB; Lloyd-Jones DM; Safford MM
JAMA; 2014 Apr; 311(14):1406-15. PubMed ID: 24682252
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease and statin eligibility.
Vega GL; Wang J; Grundy SM
J Clin Lipidol; 2021; 15(1):173-180. PubMed ID: 33191195
[TBL] [Abstract][Full Text] [Related]
5. Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD).
Shaik A; Kosiborod M; de Lemos JA; Gao Q; Mues KE; Alam S; Bhatt DL; Cannon CP; Ballantyne CM; Rosenson RS;
Clin Cardiol; 2022 Dec; 45(12):1303-1310. PubMed ID: 36124341
[TBL] [Abstract][Full Text] [Related]
6. 2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals.
Egan BM; Li J; White K; Fleming DO; Connell K; Hernandez GT; Jones DW; Ferdinand KC; Sinopoli A
J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27543306
[TBL] [Abstract][Full Text] [Related]
7. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
[TBL] [Abstract][Full Text] [Related]
8. Population Effect of Differences in Cholesterol Guidelines in Eastern Europe and the United States.
Lee JC; Zdrojewski T; Pencina MJ; Wyszomirski A; Lachacz M; Opolski G; Bandosz P; Rutkowski M; Gaciong Z; Wyrzykowski B; Navar AM
JAMA Cardiol; 2016 Sep; 1(6):700-7. PubMed ID: 27434662
[TBL] [Abstract][Full Text] [Related]
9. Association between intensity of statin therapy and mortality in persons with chronic kidney disease.
Walther CP; Richardson PA; Virani SS; Winkelmayer WC; Navaneethan SD
Nephrol Dial Transplant; 2020 Feb; 35(2):312-319. PubMed ID: 30053252
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.
Wong ND; Young D; Zhao Y; Nguyen H; Caballes J; Khan I; Sanchez RJ
J Clin Lipidol; 2016; 10(5):1109-18. PubMed ID: 27678427
[TBL] [Abstract][Full Text] [Related]
11. Implications of the 2013 ACC/AHA cholesterol guidelines on contemporary clinical practice for patients with atherosclerotic coronary and peripheral arterial disease.
Gunasekaran P; Jeevanantham V; Sharma S; Thapa R; Gupta K
Indian Heart J; 2017; 69(4):464-468. PubMed ID: 28822512
[TBL] [Abstract][Full Text] [Related]
12. Trends in Statin Use Among US Adults With Chronic Kidney Disease, 1999-2014.
Mefford MT; Rosenson RS; Deng L; Tanner RM; Bittner V; Safford MM; Coll B; Mues KE; Monda KL; Muntner P
J Am Heart Assoc; 2019 Jan; 8(2):e010640. PubMed ID: 30651020
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Wilson PWF; Polonsky TS; Miedema MD; Khera A; Kosinski AS; Kuvin JT
Circulation; 2019 Jun; 139(25):e1144-e1161. PubMed ID: 30586775
[TBL] [Abstract][Full Text] [Related]
14. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
[TBL] [Abstract][Full Text] [Related]
15. On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease - The multi-center T-SPARCLE registry study.
Ho LT; Lin FJ; Tseng WK; Yin WH; Wu YW; Li YH; Yeh HI; Chen JW; Wu CC;
J Formos Med Assoc; 2018 Sep; 117(9):814-824. PubMed ID: 29945742
[TBL] [Abstract][Full Text] [Related]
16. 2017 Taiwan lipid guidelines for high risk patients.
Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol treatment and changes in guidelines in an academic medical practice.
Schoen MW; Salas J; Scherrer JF; Buckhold FR
Am J Med; 2015 Apr; 128(4):403-9. PubMed ID: 25460526
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
[TBL] [Abstract][Full Text] [Related]
19. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
Roe MT; Li QH; Bhatt DL; Bittner VA; Diaz R; Goodman SG; Harrington RA; Jukema JW; Lopez-Jaramillo P; Lopes RD; Louie MJ; Moriarty PM; Szarek M; Vogel R; White HD; Zeiher AM; Baccara-Dinet MT; Steg PG; Schwartz GG
Circulation; 2019 Nov; 140(19):1578-1589. PubMed ID: 31475572
[TBL] [Abstract][Full Text] [Related]
20. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.
Pokharel Y; Tang F; Jones PG; Nambi V; Bittner VA; Hira RS; Nasir K; Chan PS; Maddox TM; Oetgen WJ; Heidenreich PA; Borden WB; Spertus JA; Petersen LA; Ballantyne CM; Virani SS
JAMA Cardiol; 2017 Apr; 2(4):361-369. PubMed ID: 28249067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
